Using Spirulina to boost the immune system against viral infections
Spirulina oral supplement for enhancing host resilience to virus infection
['FUNDING_OTHER'] · UNIVERSITY OF MISSISSIPPI · NIH-10897155
This study is looking at whether a Spirulina-based supplement called ImmulinaTM can help boost your immune system and improve recovery from viral infections like the flu, and it’s designed for people interested in better health during these illnesses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSISSIPPI (nih funded) |
| Locations | 1 site (UNIVERSITY, UNITED STATES) |
| Trial ID | NIH-10897155 on ClinicalTrials.gov |
What this research studies
This research investigates the potential of a Spirulina-based supplement called ImmulinaTM to enhance the body's resilience to viral infections, particularly influenza. The study involves a collaborative team of experts who will explore how this supplement can stimulate immune responses and improve recovery from respiratory viruses. Patients may be involved in trials that assess the effectiveness of ImmulinaTM in promoting better health outcomes during viral infections. The research aims to fill knowledge gaps regarding the benefits of this botanical dietary supplement.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at risk of respiratory viral infections, such as those with asthma or weakened immune systems.
Not a fit: Patients with severe allergies to Spirulina or related compounds may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a natural supplement that significantly improves immune response and recovery from viral infections for patients.
How similar studies have performed: Previous research has shown promising results with similar botanical supplements in enhancing immune responses, suggesting potential for success in this approach.
Where this research is happening
UNIVERSITY, UNITED STATES
- UNIVERSITY OF MISSISSIPPI — UNIVERSITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KHAN, IKHLAS AHMAD — UNIVERSITY OF MISSISSIPPI
- Study coordinator: KHAN, IKHLAS AHMAD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.